Zobrazeno 1 - 10
of 221
pro vyhledávání: '"Roy B. Jones"'
Autor:
Yago Nieto, Stephen Gruschkus, Benigno C. Valdez, Roy B. Jones, Paolo Anderlini, Chitra Hosing, Uday Popat, Muzaffar Qazilbash, Partow Kebriaei, Amin Alousi, Neeraj Saini, Samer Srour, Katayoun Rezvani, Jeremy Ramdial, Melissa Barnett, Alison Gulbis, Terri Lynn Shigle, Sairah Ahmed, Swaminathan Iyer, Hun Lee, Ranjit Nair, Simrit Parmar, Raphael Steiner, Bouthaina Dabaja, Chelsea Pinnix, Jillian Gunther, Branko Cuglievan, Kris Mahadeo, Sajad Khazal, Hubert Chuang, Richard Champlin, Elizabeth J. Shpall, Borje S. Andersson
Publikováno v:
Haematologica, Vol 107, Iss 4 (2021)
High-dose chemotherapy and autologous stem-cell transplant (HDC/ASCT) is standard treatment for chemosensitive relapsed classical Hodgkin lymphoma, although outcomes of high-risk relapse (HRR) patients remain suboptimal. We retrospectively analyzed a
Externí odkaz:
https://doaj.org/article/20d140bbdb7c4c2e996502cd045e920c
Autor:
Jillian R. Gunther, Bouthaina S. Dabaja, Swaminathan Padmanabhan Iyer, Richard E. Champlin, Melissa Barnett, Hubert H. Chuang, Sajad Khazal, Borje S. Andersson, Benigno C. Valdez, Neeraj Saini, Terri Lynn Shigle, Branko Cuglievan, Ranjit Nair, Chitra Hosing, Amin M. Alousi, Hun Lee, Kris Michael Mahadeo, Paolo Anderlini, Samer A. Srour, Sairah Ahmed, Simrit Parmar, Yago Nieto, Elizabeth J. Shpall, Raphael E Steiner, Muzaffar H. Qazilbash, Chelsea C. Pinnix, Uday R. Popat, Alison M. Gulbis, Partow Kebriaei, Katayoun Rezvani, Roy B. Jones, Stephen K. Gruschkus, Jeremy Ramdial
Publikováno v:
Haematologica. 107:899-908
High-dose chemotherapy and autologous stem-cell transplant (HDC/ASCT) is standard treatment for chemosensitive relapsed classical Hodgkin lymphoma, although outcomes of high-risk relapse (HRR) patients remain suboptimal. We retrospectively analyzed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23e6d7f167da9375fb35bc23947e9195
https://doi.org/10.3324/haematol.2021.278311
https://doi.org/10.3324/haematol.2021.278311
Autor:
P. Anderlini, David Marin, Rohtesh S. Mehta, Roy B. Jones, Muzaffar H. Qazilbash, Daniel R. Couriel, Kayo Kondo, U. Popat, Bethany J. Overman, Katy Rezvani, Issa F. Khouri, Betul Oran, Stefan O. Ciurea, Amin M. Alousi, Richard E. Champlin, Chitra Hosing, Gabriela Rondon, Elizabeth J. Shpall, Roland L. Bassett, Partow Kebriaei
Publikováno v:
Bone Marrow Transplantation. 56:1316-1324
Steroids remain the initial therapy for acute graft-vs.-host disease (AGVHD). Strategies to improve response and minimize steroid exposure are needed. We report results of a randomized, adaptive, Bayesian-designed, phase II trial of prednisone with o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f5eec97ab971543c6d0b0656a7a7a18
https://doi.org/10.1038/s41409-020-01188-4
https://doi.org/10.1038/s41409-020-01188-4
Autor:
Dominique Washington, Katayoun Rezvani, Amin M. Alousi, Hind Rafei, Isabel M Galvan, May Daher, Ala Abudayyeh, Samer A. Srour, Muzaffar H. Qazilbash, Peter F. Thall, Paolo Anderlini, Roy F. Chemaly, Richard E. Champlin, Betul Oran, Melissa Barnett, Elizabeth J. Shpall, Gheath Alatrash, Victor E. Mulanovich, Issa F. Khouri, Karla M Castro, Rohtesh S. Mehta, Glorette Abueg, Jeffrey J. Molldrem, Jin S. Im, Uday R. Popat, Gabriela Rondon, Neeraj Saini, Partow Kebriaei, Ruitao Lin, Pinaki P. Banerjee, Mustafa Bdaiwi, David Marin, Roy B. Jones, Indresh Kaur, Sheetal S Rao, Fleur M. Aung, Yago Nieto, Amanda Olson, Rafet Basar, Qaiser Bashir, Bryan P Spencer, Chitra Hosing, Borje S. Andersson
Publikováno v:
J Clin Oncol
PURPOSE BK virus-associated hemorrhagic cystitis (BKV-HC) is a common complication of allogenic hematopoietic stem cell transplantation (AHSCT), particularly in recipients of alternative donor transplants, which are being performed in increasing numb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76e10eb7df82456808def976870bbf65
https://europepmc.org/articles/PMC10166368/
https://europepmc.org/articles/PMC10166368/
Autor:
Ala Abudayyeh, Heather Lin, David Marin, Dimitrios P. Kontoyiannis, Richard E. Champlin, Katayoun Rezvani, Roy B. Jones, Jeffrey J. Tarrand, Maen Abdelrahim, Roy F. Chemaly, Uday R. Popat, Gabriela Rondon, Betul Oran, Borje S. Andersson, Charles Martinez, Valda D. Page, Elizabeth J. Shpall, Amanda Olson
Publikováno v:
Transplant Infectious Disease. 22
BACKGROUND BK polymavirus (BKPyV), a member of the family Polyomaviridae, is associated with increased morbidity and mortality in allogeneic stem cell transplant recipients. METHODS In our previous retrospective study of 2477 stem cell transplant pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::740bdf8bb14b5655a58726aeca01386e
https://doi.org/10.1111/tid.13395
https://doi.org/10.1111/tid.13395
Autor:
Julianne Chen, Issa F. Khouri, Rohtesh S. Mehta, Piyanuch Kongtim, Srdan Verstovsek, Elizabeth J. Shpall, Roland L. Bassett, Betul Oran, Muzaffar H. Qazilbash, Roy B. Jones, Richard Lindsay, Amanda Olson, Gabriela Rondon, Partow Kebriaei, Paolo Anderlini, Yago Nieto, Stefan O. Ciurea, Richard E. Champlin, Amin M. Alousi, Uday R. Popat, Borje S. Andersson, Chitra Hosing
Publikováno v:
Biol Blood Marrow Transplant
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol 26, iss 8
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol 26, iss 8
BACKGROUND: Optimal conditioning regimen for older patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation (HCT) is not known. Likewise, role of dose intensity is not clear. METHODS: We conducted a non-randomized prospect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bc4d79bdc2088a6ee6859b08adae625
https://pubmed.ncbi.nlm.nih.gov/32438043
https://pubmed.ncbi.nlm.nih.gov/32438043
Autor:
David Marin, Stefan O. Ciurea, Qaiser Bashir, Rohtesh S. Mehta, Elizabeth J. Shpall, Roland L. Bassett, Jin S. Im, Roy B. Jones, Simrit Parmar, Julianne Chen, Jitesh D. Kawedia, Amin M. Alousi, Sairah Ahmed, Geath Al-Atrash, Partow Kebriaei, Richard E. Champlin, Samer A. Srour, Benigno C. Valdez, Muzaffar H. Qazilbash, Katayoun Rezvani, Issa F. Khouri, Nina Shah, Uday R. Popat, Yago Nieto, Amanda Olson, Borje S. Andersson, Chitra Hosing, Paolo Anderlini, Betul Oran
Publikováno v:
The Lancet. Haematology, vol 5, iss 11
Summary Background Haemopoietic stem-cell transplantation (HCT) conditioning regimens that can reduce risk of relapse without increasing non-relapse mortality are needed. We aimed to test the safety of timed-sequential delivery of low-dose versus hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a1f149b753b2702a67f73f161f9e873
https://doi.org/10.1016/s2352-3026(18)30156-x
https://doi.org/10.1016/s2352-3026(18)30156-x
Autor:
Matthew Prestegaard, Krishna V. Komanduri, Roy B. Jones, Martin Maiers, Navneet S. Majhail, Charles Martinez, Mitchell E. Horwitz
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:659-665
Informatics strategies and applications available to stem cell transplant (SCT) programs are diverse and changing rapidly. Although most hospitals have electronic medical records (EMRs), few are equipped with specialized SCT applications. Most EMRs d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88ad9b8b51282197b38f51d2c8db49df
https://doi.org/10.1016/j.bbmt.2017.12.792
https://doi.org/10.1016/j.bbmt.2017.12.792
Autor:
Celina Ledesma, Roy B. Jones, Partow Kebriaei, Chitra Hosing, Issa F. Khouri, Borje S. Andersson, Krina K. Patel, Sairah Ahmed, Stefan O. Ciurea, Qaiser Bashir, Amin M. Alousi, Genevieve Lyons, Betul Oran, Uday R. Popat, Amanda Olson, Elizabeth J. Shpall, Roland L. Bassett, Gabriela Rondon, Nina Shah, David Marin, Muzaffar H. Qazilbash, Richard E. Champlin, Ben C. Valdez, Yago Nieto, Katayoun Rezvani
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:285-292
We investigated the long-term safety and disease control data obtained with i.v. busulfan (Bu) combined with clofarabine (Clo) in patients with acute lymphoblastic leukemia (ALL) undergoing allogeneic hematopoietic stem cell transplantation (HSCT). A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b29f4e1e5e05f6dbb4afad24a72242d
https://doi.org/10.1016/j.bbmt.2016.11.001
https://doi.org/10.1016/j.bbmt.2016.11.001
Autor:
Benigno C. Valdez, Roy B. Jones, Katayoun Rezvani, Borje S. Andersson, Uday R. Popat, Partow Kebriaei, Julianne Chen, Simrit Parmar, Yago Nieto, Amin M. Alousi, Richard E. Champlin, Qaiser Bashir, Steven M. Kornblau, Sairah Ahmed, Alan L. Myers, Chitra Hosing, Nina Shah, Junsheng Ma, Stefan O. Ciurea, Betul Oran, Elizabeth J. Shpall, Alison M. Gulbis, Peter F. Thall, Jitesh D. Kawedia
Publikováno v:
Blood. 136:37-38
Disease relapse remains the major cause of treatment failure following hematopoietic transplantation for AML/MDS. A major goal is to develop more effective antileukemic regimens without excessive toxicity. Fludarabine (Flu) with IV Busulfan (Bu) rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84cd15e494a12e6d8ea94b8ca0603981
https://doi.org/10.1182/blood-2020-142680
https://doi.org/10.1182/blood-2020-142680